Avoided Costs Through Medication Reliability: Reducing ED Use and Preventable Harm in HCBS and LTSS

Medication issues are one of the most common, preventable triggers of avoidable demand in community-based care—especially for people with multiple prescribers, cognitive impairment, or unstable routines. Many “avoidable” ED visits are actually system failures: missing refills, untracked medication changes, or side effects that go unrecognized until they become urgent. This sits within Avoided Costs & Demand Reduction and connects tightly to Transitions and Care Coordination, because medication reliability is most fragile after discharge and service changes.

Two oversight expectations shape how commissioners and MCOs evaluate this work. First, they expect medication safety in HCBS/LTSS to be operationalized as a repeatable process (roles, steps, escalation thresholds), not treated as “the member’s responsibility.” Second, they expect demand-reduction claims to be auditable: a reviewer should be able to trace a medication risk, see the actions taken, and link those actions to avoided escalation.

Why medication reliability is a demand-reduction lever

Medication non-adherence and medication harm are often framed as individual behavior problems. In real services, they frequently emerge from workflow gaps: discharge lists not reconciled, pharmacies switching generics without the member understanding, duplication across specialists, or staff not knowing when a “normal” side effect is actually a deterioration signal. A credible avoided-cost strategy doesn’t aim to eliminate all risk; it aims to reduce preventable breakdowns and shorten the time between risk appearing and corrective action.

Operational Example 1: Post-change medication reconciliation with closed-loop confirmation

What happens in day-to-day delivery

Whenever the provider learns of a medication change (hospital discharge, specialist visit, new prescription, discontinued drug), a defined reconciliation workflow starts. A designated role—often a nurse, care coordinator, or trained lead—collects the “current list” from at least two sources (e.g., discharge paperwork and pharmacy profile) and compares it to the service plan medication record. Discrepancies are logged as tasks: clarify with prescriber, confirm with pharmacy, update the member-facing list, and brief frontline staff on what changed. The workflow is not complete until a closed-loop confirmation is recorded (who confirmed, when, and what was confirmed).

Why the practice exists (failure mode it addresses)

This practice exists to prevent duplication, omission, and “shadow prescribing,” where multiple lists circulate and staff administer or support the wrong regimen. It also prevents the common failure where a change is documented somewhere in the system but never translated into what the member and frontline staff actually do.

What goes wrong if it is absent

Medication lists drift. A discontinued medication remains in use, an added medication is never started, or staff support the old dose. Side effects are misattributed to “baseline” behavior. The member deteriorates gradually until the first visible point is a fall, confusion episode, hypoglycemia event, or urgent ED presentation—often recorded as “non-compliance” rather than system error.

What observable outcome it produces

Providers can evidence timeliness and completeness: percent of changes reconciled within a set timeframe, discrepancy rates by source, and documented confirmations. On the demand side, they can show fewer medication-related incident reports, fewer urgent calls after transitions, and reduced ED utilization attributed to medication issues—supported by an audit trail linking change detection to corrective action.

Operational Example 2: Adherence reliability checks embedded in routine contacts

What happens in day-to-day delivery

Rather than relying on sporadic “med reviews,” the provider embeds adherence reliability checks into routine contacts. Frontline staff use a brief, consistent script: confirm the member has medication in the home, verify refill timing, check whether doses were missed, and ask targeted questions about side effects that matter for that medication class (e.g., dizziness, confusion, appetite changes). Findings are recorded in structured fields so supervisors can trend them. If the member has cognitive impairment, staff also confirm that the support method is working (pill organizer filled correctly, reminders effective, caregiver available).

Why the practice exists (failure mode it addresses)

This exists to prevent “silent non-adherence,” where missed doses or side effects build risk quietly. In HCBS and LTSS, the system often assumes adherence until a crisis proves otherwise. Routine checks turn adherence into a monitored delivery variable.

What goes wrong if it is absent

Providers only learn about adherence failure after a visible event—falls, behavioral dysregulation, pain crisis, or disease flare. Staff report “the member seemed fine last week,” because no one asked the specific questions that would have revealed missed refills, confusion about dosing, or intolerable side effects driving avoidance.

What observable outcome it produces

Providers can show earlier interventions: refill support initiated before medication runs out, prescriber contact triggered by side effects, or caregiver coaching delivered before disengagement. Evidence includes reduced missed-dose frequency among monitored members, fewer medication-related escalation incidents, and more timely issue resolution documented in case notes and supervision logs.

Operational Example 3: Medication-risk escalation thresholds that trigger clinical review

What happens in day-to-day delivery

The provider defines clear escalation thresholds tied to medication risk, not just general health concerns. Examples include: two or more missed doses of a critical medication in a week, repeated refusal due to side effects, or new confusion after a psychoactive medication change. When a threshold is met, the escalation pathway is immediate: notify supervisor, initiate same-day clinical check (nurse or clinical lead), and document the decision and next steps (prescriber call, urgent appointment, safety plan update). Escalations are reviewed in weekly governance meetings to confirm thresholds are applied consistently.

Why the practice exists (failure mode it addresses)

This exists to prevent ambiguous decision-making. Without thresholds, staff either escalate too late (because they normalize changes) or escalate inconsistently (because decisions depend on who is on shift). Thresholds create predictable, defensible actions that protect safety while reducing crisis demand.

What goes wrong if it is absent

Medication risk is managed informally. Early warning signs are missed or minimized until they become acute. Commissioners see ED use that appears “unavoidable,” but the provider cannot demonstrate that specific opportunities for earlier intervention were recognized and acted on.

What observable outcome it produces

Providers can evidence consistency: escalation rates by threshold type, response times, and outcomes of clinical review (medication adjustment, monitoring plan, caregiver education). Demand reduction becomes credible when ED events drop among those with documented medication-risk monitoring, supported by clear timelines from threshold detection to intervention.

How to report medication-linked avoided costs without overclaiming

Medication reliability is a strong demand-reduction narrative when framed as “prevented breakdowns” rather than guaranteed savings. The most defensible approach is to report process integrity (reconciliation timeliness, adherence checks completed, escalation response times) alongside utilization signals (ED visits, urgent calls, falls) and explicitly connect them through case-level audit trails and governance review.